CoChat

The DOI matches its Crossref record; 148 of the 148 references it cites were found in a registry or an index; none of the 149 sources its claims cite is checked for support yet.

Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection

Open access
Sun, Bingyue, Ling, Yaozheng, Li, Junhui, Ma, Li, Jie, Zige, Luo, Hongbing, Li, Yang, Yin, Guo, Wang, Mingwei, Meng, Fanzheng, Gao, Man · 2025 · Frontiers in Microbiology

Abstract

Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia (CAP) and upper respiratory tract infections, particularly in children and immunocompromised individuals. The growing global prevalence of macrolide-resistant M. pneumoniae (MRMP) further emphasizes the urgent need to elucidate its pathogenic mechanisms. Among these, adhesion plays a central role, serving as a prerequisite for colonization and disease progression, and thus warrants detailed investigation. The terminal organelle of M. pneumoniae mediates both adhesion and gliding motility, facilitating colonization, tissue invasion, and potential systemic spread. In the lung, adhesion triggers cytotoxic effects through the release of hydrogen peroxide (H 2 O 2) and CARDS toxin (CARDS TX), promotes excessive inflammatory responses, and enables immune evasion via antigenic variation. Extrapulmonary manifestations may also arise either from direct bacterial dissemination or autoimmune responses induced by molecular mimicry between bacterial and host antigens. In addition, recent advances suggest that therapies and vaccines directed at the adhesion mechanism of M. pneumoniae may offer promising strategies for combating MRMP infections. Although progress has been made, the adhesion-related pathogenesis of M. pneumoniae, as well as the prospects for therapies and vaccines targeting this mechanism, remains incompletely defined. This review synthesizes current insights into adhesion-mediated mechanisms and highlights emerging therapeutic strategies targeting adhesion, aiming to support more effective treatment and prevention of M. pneumoniae infection.

Overview

CoChat Summary

TL;DR

This review synthesizes current evidence that *Mycoplasma pneumoniae* adhesion, mediated mainly by its terminal organelle and adhesins such as P1, is central to colonization, gliding motility, cytotoxicity, inflammation, immune evasion, extrapulmonary disease, and asymptomatic carriage. It also highlights adhesion-targeted therapies and vaccines as promising strategies amid rising macrolide resistance, while noting that key mechanisms and vaccine prospects remain incompletely defined.

Key findings

  • Adhesion is a prerequisite for infection: the terminal organelle uses P1, P90/P40, P30, and accessory proteins to bind sialylated oligosaccharides, with α-2,3-sialyllactose showing relatively high affinity; P1-deficient strains lose adhesion and become non-pathogenic. Gliding occurs via a catch-pull-release cycle, and PrkC promotes HMW1/HMW2 phosphorylation to enhance motility while PrpC opposes it.
  • Post-adhesion pathogenesis includes H2O2 production from glycerol/G3P metabolism via GlpD, and CARDS TX, a 591-amino-acid ADP-ribosylating and vacuolating toxin that binds SP-A, annexin A2, phosphatidylcholine, and sphingomyelin and induces Rab9-enriched vacuoles. Adhesion also triggers IL-1β, IL-6, IL-8, and TNF-α and supports immune evasion through antigenic variation, PrkC-mediated phosphorylation, and factor H binding.
  • Extrapulmonary and carriage mechanisms involve direct adhesion to macrophages and erythrocytes, hemolysis, and molecular mimicry with GalC/myelin/keratinocyte antigens; asymptomatic carriage is associated with largely undetectable mucosal IgG/IgA against P1, P30, and P116, reduced upper respiratory microbiota diversity, and increased *Haemophilus influenzae*.
  • Clinically, *M. pneumoniae* accounts for about 10–30% of community-acquired pneumonia cases and has a genome of about 816 kbp; macrolide resistance involves 23S rRNA mutations A2063G and A2064G, and the P1-2 genotype is increasingly linked to high-level macrolide resistance. Adhesion-targeted candidates include Platycodin D, *Melipona quadrifasciata* propolis methanolic extract, cyclosporin A, and vaccine antigens P1, P30, P116, and chimeric MP559; P1 aa 1288–1518 and P30 aa 17–274 are immunoreactive, but no vaccine candidates have advanced to clinical trials.

Methods

  • Design: narrative review; no primary experiments or systematic review protocol are reported.
  • Data: published literature on *M. pneumoniae* adhesion, gliding, intrapulmonary and extrapulmonary pathogenesis, asymptomatic carriage, treatment, and vaccine development.
  • Main analysis: thematic synthesis of terminal organelle structure/function, adhesion and gliding mechanisms, adhesion-related immune and toxic mechanisms, clinical significance, and adhesion-targeted therapeutic and vaccine strategies.

Limitations

  • The paper states that the precise molecular mechanisms of post-adhesion cytotoxicity and systemic tissue damage remain to be fully elucidated; adhesion-related pathogenesis and therapy/vaccine prospects remain incompletely defined; hepatotropic pathogenesis requires further evidence; and no vaccine candidates have advanced to clinical trials, with vaccine-enhanced disease (VED) a concern for LAMP-containing formulations.
  • Evident from the text: as a narrative review, it lacks a described systematic search strategy, inclusion criteria, or formal quality appraisal; it relies on cited studies without original data, and some proposed mechanisms are speculative, such as P30 functioning as a rotational-to-linear mechanotransducer and the analogy to *M. genitalium* “stealth survival” strategies.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fmicb.2025.1613760

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 (A) A pattern map of the terminal organelle’s structures. (B) The structures of the proteins in the terminal organelle and their relative positions. The 3D structures of the proteins are visualized by PyMOL software based on their amino acid sequences from NCBI, while their relative positions are described based on the core image and recent mapping results from Hamaguchi (2016).
FIGURE 1 (A) A pattern map of the terminal organelle’s structures. (B) The structures of the proteins in the terminal organelle and their relative positions. The 3D structures of the proteins are visualized by PyMOL software based on their amino acid sequences from NCBI, while their relative positions are described based on the core image and recent mapping results from Hamaguchi (2016).CC BY · PubMed Central
FIGURE 2 M. pneumoniae employs specialized adherence organelles and glycolytic enzymes to establish adhesion to respiratory epithelial cells. Notably, distinct glycolytic enzymes mediate host cell attachment by interacting with different ECM proteins, as indicated by dashed lines in the schematic representation (Grundel et al., 2016). When adhering to integrins, the pathogen forms an FA-like structure. This structure achieves mechanical stability through adaptor proteins, including talin, vinculin, and paxillin, which anchor the adhesion complex to intracellular actin filaments, creating a robust host-pathogen interface.
FIGURE 2 M. pneumoniae employs specialized adherence organelles and glycolytic enzymes to establish adhesion to respiratory epithelial cells. Notably, distinct glycolytic enzymes mediate host cell attachment by interacting with different ECM proteins, as indicated by dashed lines in the schematic representation (Grundel et al., 2016). When adhering to integrins, the pathogen forms an FA-like structure. This structure achieves mechanical stability through adaptor proteins, including talin, vinculin, and paxillin, which anchor the adhesion complex to intracellular actin filaments, creating a robust host-pathogen interface.CC BY · PubMed Central
FIGURE 3 (A) The gliding mechanism of M. pneumoniae. P1 adhesin binds to the host cell surface through a catch-pull-release cycle with SOS. During the terminal organelle’s extension, P1 retracts from SOS, and during contraction, P1 binds to SOS tightly, while the iterative extension and retraction of the terminal organelle generate gliding movement. (B) The P1 and P30 proteins of M. pneumoniae may exhibit functional homology to the Gli349 and Gli521 adhesins in M. mobile, suggesting conserved molecular mechanisms underlying mycoplasma motility. (C) From the host’s perspective, when the integrin binds to the substrate, myosin generates force, actin contracts, and the substrate detaches, thereby promoting the sliding of M. pneumoniae on the cell membrane. (D) The internal force direction of the core structure. The terminal organelle forces originate in the bowl complex, travel through MPN387 to the paired plates, and then lead to extension and retraction of the terminal organelle. (E) PrkC promotes the phosphorylation of HMW1 and HMW2 proteins to enhance M. pneumoniae gliding motility, whereas PrpC functions opposite manner.
FIGURE 3 (A) The gliding mechanism of M. pneumoniae. P1 adhesin binds to the host cell surface through a catch-pull-release cycle with SOS. During the terminal organelle’s extension, P1 retracts from SOS, and during contraction, P1 binds to SOS tightly, while the iterative extension and retraction of the terminal organelle generate gliding movement. (B) The P1 and P30 proteins of M. pneumoniae may exhibit functional homology to the Gli349 and Gli521 adhesins in M. mobile, suggesting conserved molecular mechanisms underlying mycoplasma motility. (C) From the host’s perspective, when the integrin binds to the substrate, myosin generates force, actin contracts, and the substrate detaches, thereby promoting the sliding of M. pneumoniae on the cell membrane. (D) The internal force direction of the core structure. The terminal organelle forces originate in the bowl complex, travel through MPN387 to the paired plates, and then lead to extension and retraction of the terminal organelle. (E) PrkC promotes the phosphorylation of HMW1 and HMW2 proteins to enhance M. pneumoniae gliding motility, whereas PrpC functions opposite manner.CC BY · PubMed Central
FIGURE 4 The adhesion-associated toxin mechanism of M. pneumoniae, including H2O2 and CARDS TX.
FIGURE 4 The adhesion-associated toxin mechanism of M. pneumoniae, including H2O2 and CARDS TX.CC BY · PubMed Central
FIGURE 5 The CARDS TX structure mapped by PyMoL with the main pathogenic mechanism. (A) The 3D protein structure of CARDS TX mapped by PyMOL. (B) The N-terminal Arg (R10), Asp (D12), Arg (R14), His (H36), and the mid-region Ser-Thr-Ser (S49-T50-S51) can bind with NAD+ to facilitate ADP ribosylation. (C) The C-terminal (Y571-F591) is integral to proper D3 folding for facilitating vacuolation.
FIGURE 5 The CARDS TX structure mapped by PyMoL with the main pathogenic mechanism. (A) The 3D protein structure of CARDS TX mapped by PyMOL. (B) The N-terminal Arg (R10), Asp (D12), Arg (R14), His (H36), and the mid-region Ser-Thr-Ser (S49-T50-S51) can bind with NAD+ to facilitate ADP ribosylation. (C) The C-terminal (Y571-F591) is integral to proper D3 folding for facilitating vacuolation.CC BY · PubMed Central
FIGURE 6 The adhesion-related mechanisms of M. pneumoniae in extrapulmonary infection.
FIGURE 6 The adhesion-related mechanisms of M. pneumoniae in extrapulmonary infection.CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 10 Not valid · 115 Not checked · 23 Own results and interpretations

75 more claims

Create a free account to see all 148 claims and to verify the 129 references still open.

See all claims — free account
  • It may state two separate claims as one. 58
  • Probably not a substantial claim. 14

Create a free account to see these claims.

Citations

Cites

Show all 148 references

Metadata

Authors
Sun, B., Ling, Y., Li, J., Ma, L., Jie, Z., Luo, H., Li, Y., Yin, G., Wang, M., Meng, F., & Gao, M.
Affiliations
  • First Hospital of Jilin University (CN)
  • Jilin University (CN)
Corresponding author
  • Meng, Fanzheng
  • Gao, Man
Venue
Frontiers in Microbiology
Published
2025-07-23
Volume
16
Pages
1613760-1613760
ISSN
1664-302X (ISSN-L)
OpenAlex
W4412583919
Cited by
18
References
148
Citations by year
2026: 15 · 2025: 3
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Microbiology (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
People's Government of Jilin Province
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
Keywords
Mycoplasma pneumoniae, bacterial adhesion, macrolide resistance, community-acquired pneumonia, gliding motility, hydrogen peroxide, CARDS toxin, immune evasion, antigenic variation, molecular mimicry, autoimmune disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection. https://app.cochat.ai/papers/10.3389/fmicb.2025.1613760
The paper
Sun, B., Ling, Y., Li, J., Ma, L., Jie, Z., Luo, H., Li, Y., Yin, G., Wang, M., Meng, F., & Gao, M. (2025). Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2025.1613760

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.